Menu

Lipella Pharmaceuticals Inc. LIPO

Full chart Compare
Set alert

Price alert · LIPO

All alert types
0.00 USD 0.00 (+0.00%)

At closeNov 6, 2026, 4:00 PM EST

1.80 +1.80 +359,920.00%

After hours · Nov 6, 4:00 PM ET

0.0327 Day range 0.058
0.0002 52-week range 0.545
YTD
-99.72%
1 year
-99.86%

Revenue & Expenses

Other Income → Expenses: $64.28KExpenses → Selling, General & Admin: $2.00MExpenses → Research & Development: $3.61MGross Profit → Expenses: $536.36KRevenue → Gross Profit: $536.36KNet Loss → Expenses: $5.02MOther Income$64.28KGross Profit$536.36KNet Loss$5.02MExpenses$5.62MSelling, General & Admin$2.00MResearch & Development$3.61MRevenue$536.36K

Latest period ending Dec 31, 2024 · select a line to chart its full history

LIPO annual income statement
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
536.36K449.62K184.16K259.35K961.68K
536.36K449.62K184.16K259.35K961.68K
-5.08M-4.75M-2.59M-1.92M-56.86K
-5.02M-4.62M-2.60M-1.87M-61.66K
-4.79-6.16-5.12-4.40-0.08
LIPO annual balance sheet
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
2.18M3.29M5.12M1.41M606.74K
2.67M3.58M5.95M2.01M955.02K
754.42K432.73K1.27M589.34K491.70K
47.60K136.59K433.12K340.75K439.87K
1.92M3.14M4.68M1.42M463.32K
LIPO annual cash flow
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
-3.95M-3.15M-1.83M-989.27K-28.58K
2.84M1.34M5.24M2.10M609.31K
-1.11M-1.83M3.71M807.09K580.73K